NHS set to benefit from £23 million following CMA pharma probe
The Competition and Markets Authority’s (CMA’s) investigation, which launched earlier this year, considered whether Vifor Pharma – which makes the intravenous iron deficiency treatment Ferinject – had restricted competition by…